No black box warning on record for Ilumya
As of the latest FDA labeling reviewed, Ilumya (TILDRAKIZUMAB-ASMN) does not carry a black box warning. Standard warnings and precautions still apply — see the full Ilumya medicine page for the complete safety profile.